SUPN ์ต์ ๋ถ๊ธฐ ์์ต
๋ฐํ ๋ ์ง8/3/2026
EPS ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)-1.01
์์ต ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)219.06M
Supernus Pharmaceuticals Inc ์ค์ ๋ฐํ ๋ ์ง ๋ฐ ๋ณด๊ณ ์
์ด ํ์ด์ง๋ ์ต์ Supernus Pharmaceuticals Inc ์์ต ๋ณด๊ณ ์, ๋ค๊ฐ์ค๋ Supernus Pharmaceuticals Inc ์ค์ ๋ฐํ ๋ ์ง, ๊ณผ๊ฑฐ ๋ฐ์ดํฐ ๋ฐ Supernus Pharmaceuticals Inc ์ค์ ๋ฐํ ์ปจํผ๋ฐ์ค ๋ด์ค๋ฅผ ํฌํจํ ์์ธํ Supernus Pharmaceuticals Inc ์์ต ๋ฐ์ดํฐ๋ฅผ ์ ๊ณตํฉ๋๋ค.
SUPN ํฅํ ๋ถ๊ธฐ ์ค์
๋ฐํ ๋ ์ง--
EPS ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
์์ต ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
SUPN FY2025 ์์ต
์ฐ๊ฐ ์ฃผ๋น์์ด์ต ์ฑ์ฅ๋ฅ (YoY)-0.68-150.94%
์ฐ๊ฐ ๋งค์ถ ์ฑ์ฅ๋ฅ (YoY)718.95M8.63%
Supernus Pharmaceuticals Inc(SUPN) ์ค์ ๋ด์ญ
| ๋ฐํ์ผ | ๊ธฐ๊ฐ ์ข ๋ฃ | EPS/์์ | ์์ต/์์ | EPS ์ํ๋ผ์ด์ฆ % | ์์ต ์ํ๋ผ์ด์ฆ % |
|---|---|---|---|---|---|
| 8/3/2026 | 06/2026 | -1.01/0.36 | 219.06M/204.96M | -382.35% | 6.88% |
| 5/5/2026 | 03/2026 | -0.04/0.30 | 207.71M/192.92M | -113.37% | 7.67% |
| 2/24/2026 | 12/2025 | -0.07/0.34 | 211.57M/195.00M | -121.03% | 8.50% |
| 11/4/2025 | 09/2025 | -0.80/0.59 | 192.10M/178.89M | -235.22% | 7.39% |
| 8/5/2025 | 06/2025 | 0.40/0.47 | 165.45M/154.06M | -14.56% | 7.39% |
| 5/6/2025 | 03/2025 | -0.21/0.37 | 149.82M/147.94M | -156.71% | 1.28% |
| 2/25/2025 | 12/2024 | 0.28/0.41 | 174.16M/155.25M | -33.41% | 12.18% |
| 11/4/2024 | 09/2024 | 0.70/0.44 | 175.69M/157.30M | 57.45% | 11.69% |